티스토리 뷰
[리보핵산가수분해효소 억제제] NZYRibonuclease Inhibitor [MB08401, MB08402]_NZYTech - 코아사이언스
코피디 2023. 7. 28. 16:08NZY Ribonuclease Inhibitor inhibits the activity of ribonucleases (RNases; EC 3.1) of the pancreatic type. It is not active against RNase 1, RNase T1, RNase T2, S1 nuclease and RNase H.
NZY Ribonuclease Inhibitor is a recombinant protein purified from Escherichia coli. It inhibits the activity of ribonucleases (RNases; EC 3.1) of the pancreatic type, such as RNase A, RNase B and RNase C, by binding them noncovalently in a 1:1 ratio. NZY Ribonuclease Inhibitor is useful in any application where RNase contamination is a potential problem. For instance, it can be used to protect template RNA in cDNA synthesis reactions, RT-PCR or in vitrotranscription/translation, as well as to protect viral RNA during in vitro replication. In addition, it will inhibit RNases during RNA isolation and purification and during RNase-free antibodies preparation. NZY Ribonuclease Inhibitor is not active against RNase 1, RNase T1, RNase T2, S1 nuclease and RNase H.
Component:
– Ribonuclease Inhibitor (40 U/µL)
Application:
- cDNA synthesis, RT-PCR, RT-qPCR
Shipping Conditions
|
Dry Ice
|
Storage Conditions
|
-85 °C to -15 °C
|
Format
|
Enzyme/Protein, Liquid
|
Product Category
|
RNA Protection
|
Reaction Temperature
|
50 °C
|
* 본 상품은 오직 연구용으로만 사용 가능합니다. 인체 및 제품화에 사용하실 수 없습니다.
코아사이언스 coresciences NZYTech, Lda. genes & enzymes korea 한국 molecular biology 분자생물학 enzymes & proteins 효소 단백질 assay kits 분석 측정 테스트 키트
'연구용 시약' 카테고리의 다른 글
- Total
- Today
- Yesterday
- 건스터바이오텍
- 조직절편
- 코아사이언스
- allview PAGE buffer
- filter
- Funakoshi
- OLED
- 고수용성 콘드로이틴
- 연속절편
- 파라핀 블록
- 바이오하자드백
- 파라핀 블럭
- 면역화학분석
- 형광염색
- 후나코시
- 조직염색절편제작
- OPV
- 콘드로이틴 황산 올리고당
- 조직절편제작
- material science
- time release pellets
- 미니멸균백
- 막필터
- matrix-driven delivery pellet
- gradient gel
- Sterlitech
- 바이오헤저드백
- 오토클레이브백
- solar cells
- Coresciences
일 | 월 | 화 | 수 | 목 | 금 | 토 |
---|---|---|---|---|---|---|
1 | ||||||
2 | 3 | 4 | 5 | 6 | 7 | 8 |
9 | 10 | 11 | 12 | 13 | 14 | 15 |
16 | 17 | 18 | 19 | 20 | 21 | 22 |
23 | 24 | 25 | 26 | 27 | 28 |